» Articles » PMID: 35736467

Recent Advances in (Licorice)-Containing Herbs Alleviating Radiotherapy- and Chemotherapy-Induced Adverse Reactions in Cancer Treatment

Overview
Journal Metabolites
Publisher MDPI
Date 2022 Jun 23
PMID 35736467
Authors
Affiliations
Soon will be listed here.
Abstract

Cancers represent a significant cause of morbidity and mortality worldwide. They also impose a large economic burden on patients, their families, and health insurance systems. Notably, cancers and the adverse reactions to their therapeutic options, chemotherapy and radiotherapy, dramatically affect the quality of life of afflicted patients. Therefore, developing approaches to manage chemotherapy- and radiotherapy-induced adverse reactions gained greater attention in recent years. (licorice), a perennial plant that is one of the most frequently used herbs in traditional Chinese medicine, has been heavily investigated in relation to cancer therapy. Licorice/licorice-related regimes, used in combination with chemotherapy, may improve the adverse effects of chemotherapy. However, there is little awareness of licorice-containing herbs alleviating reactions to radiotherapy and chemotherapy, or to other induced adverse reactions in cancer treatment. We aimed to provide a descriptive review, and to emphasize the possibility that licorice-related medicines could be used as an adjuvant regimen with chemotherapy to improve quality of life (QoL) and to reduce side effects, thus, improving compliance with chemotherapy. The experimental method involved searching different databases, including PubMed, the Cochrane Library, and Wang Fang database, as of May 2022, to identify any relevant studies. Despite a lack of high-quality and large-scale randomized controlled trials, we still discovered the potential benefits of licorice-containing herbs from published clinical studies. These studies find that licorice-containing herbs, and their active ingredients, reduce the adverse reactions caused by chemotherapy and radiotherapy, and improve the QoL of patients. This comprehensive review will serve as a cornerstone to encourage more scientists to evaluate and develop effective Traditional Chinese medicine prescriptions to improve the side effects of chemotherapy and radiation therapy.

Citing Articles

Enhanced tumor suppression in colorectal cancer via berberine-loaded PEG-PLGA nanoparticles.

Shen F, Zheng Y, Dong L, Cao Z, Cao J Front Pharmacol. 2024; 15:1500731.

PMID: 39555093 PMC: 11563832. DOI: 10.3389/fphar.2024.1500731.


Sini decoction-polysaccharide compound regulates proliferation, apoptosis, and glycolysis of liver cancer cells through PHLDA2/ANXA2.

Shen C, Huang P, Xie W, Ni X, Gao J Transl Cancer Res. 2024; 13(10):5574-5587.

PMID: 39525010 PMC: 11543045. DOI: 10.21037/tcr-24-1625.


Non-surgical nursing care for tumor patients: an overview of sedation, analgesia, and recent innovations.

Wei W, Wang P, Qing P, Li Z, He Q Front Oncol. 2024; 14:1322196.

PMID: 39355133 PMC: 11443224. DOI: 10.3389/fonc.2024.1322196.


Matching traditional Chinese medicine and western medicine-based research: Advanced nutraceutical development for proactive gastric cancer prevention.

Micucci M, Xiang B, Ting C, Kwan H, Mari M, Retini M World J Gastrointest Oncol. 2024; 16(9):3798-3819.

PMID: 39350981 PMC: 11438774. DOI: 10.4251/wjgo.v16.i9.3798.


Non-thermal atmospheric pressure plasma induces selective cancer cell apoptosis by modulating redox homeostasis.

Yun J, Yang Y, Han C, Kang S, Kim C Cell Commun Signal. 2024; 22(1):452.

PMID: 39327567 PMC: 11426099. DOI: 10.1186/s12964-024-01810-8.


References
1.
Seike J, Sawada T, Kawakita N, Yamamoto Y, Yuasa Y, Yamai H . A New Candidate Supporting Drug, Rikkunshito, for the QOL in Advanced Esophageal Cancer Patients with Chemotherapy Using Docetaxel/5-FU/CDDP. Int J Surg Oncol. 2012; 2011:715623. PMC: 3263686. DOI: 10.1155/2011/715623. View

2.
Zhou Y, Liu D, Chen S, Chen N, Sun J, Wang X . Nrf2 activation ameliorates mechanical allodynia in paclitaxel-induced neuropathic pain. Acta Pharmacol Sin. 2020; 41(8):1041-1048. PMC: 7470811. DOI: 10.1038/s41401-020-0394-6. View

3.
Liu S, Cheng Y . Old formula, new Rx: the journey of PHY906 as cancer adjuvant therapy. J Ethnopharmacol. 2012; 140(3):614-23. DOI: 10.1016/j.jep.2012.01.047. View

4.
Armanini D, Nacamulli D, Francini-Pesenti F, Battagin G, Ragazzi E, Fiore C . Glycyrrhetinic acid, the active principle of licorice, can reduce the thickness of subcutaneous thigh fat through topical application. Steroids. 2005; 70(8):538-42. DOI: 10.1016/j.steroids.2005.01.007. View

5.
Qi F, Li A, Inagaki Y, Gao J, Li J, Kokudo N . Chinese herbal medicines as adjuvant treatment during chemo- or radio-therapy for cancer. Biosci Trends. 2011; 4(6):297-307. View